C Burkhart
The influence of clinical risk factors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients
Biccard B, Lurati Buse G, Burkhart C, Cuthbertson B, Filipovic M, Gibson S, Mahla E, Leibowitz D, Rodseth R. The influence of clinical risk factors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients. Anaesthesia 2011; 67:55-9.
Nov 8, 2011The influence of clinical risk factors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients
Nov 8, 2011Anaesthesia 2011; 67:55-9
Biccard B M, Lurati Buse G A, Burkhart C, Cuthbertson B H, Filipovic Miodrag, Gibson S C, Mahla E, Leibowitz D W, Rodseth R N
Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection
Maloy K, Zinkernagel R, Hoffmann-Rohrer U, Ludewig B, Theofilopoulos A, Kono D, Pircher H, Rülicke T, Freer G, Burkhart C, Hengartner H. Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection. Journal of immunology (Baltimore, Md. : 1950) 1999; 162:2867-74.
Mar 1, 1999Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection
Mar 1, 1999Journal of immunology (Baltimore, Md. : 1950) 1999; 162:2867-74
Maloy K J, Zinkernagel R M, Hoffmann-Rohrer U, Ludewig Burkhard, Theofilopoulos A N, Kono D H, Pircher H, Rülicke T, Freer G, Burkhart C, Hengartner H